Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus-Alexander Wörns

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Systemic therapy and synergies by combinationMarcus-Alexander Wörns
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2020
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinomaLorenza Rimassa, Marcus-Alexander Wörns
Nature Reviews. Gastroenterology & Hepatology|February 5, 2014
HCC therapies--lessons learnedMarcus-Alexander Wörns, Peter Robert Galle
Expert Opinion on Investigational Drugs|April 9, 2010
Novel inhibitors in development for hepatocellular carcinomaMarcus Alexander Wörns, Peter Robert Galle
Hepatic Oncology|September 8, 2018
Sorafenib for the treatment of hepatocellular carcinomaMarcus Alexander Wörns, Peter Robert Galle
Digestive Diseases (Basel, Switzerland)|June 24, 2009
Systemic therapies in hepatocellular carcinomaMarcus Alexander Wörns, Arndt Weinmann, Marcus Schuchmann, et al.
Zeitschrift Fur Gastroenterologie|November 25, 2021
Prescription rates of common medications in patients with decompensated cirrhosis in GermanyChristian Labenz, Karel Kostev, Peter Robert Galle, et al.
Oncology|November 13, 2010
Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatmentMarcus Alexander Wörns, Marcus Schuchmann, Christoph Düber, et al.
Deutsches Arzteblatt International|September 21, 2017
Drug Treatment for Chronic Hepatitis C Infection and Cancer RiskMarcus-Alexander Wörns, Peter Robert Galle, Stefan Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Systemic therapy and synergies by combinationMarcus-Alexander Wörns
Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2020
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinomaLorenza Rimassa, Marcus-Alexander Wörns
Nature Reviews. Gastroenterology & Hepatology|February 5, 2014
HCC therapies--lessons learnedMarcus-Alexander Wörns, Peter Robert Galle
Expert Opinion on Investigational Drugs|April 9, 2010
Novel inhibitors in development for hepatocellular carcinomaMarcus Alexander Wörns, Peter Robert Galle
Hepatic Oncology|September 8, 2018
Sorafenib for the treatment of hepatocellular carcinomaMarcus Alexander Wörns, Peter Robert Galle
Digestive Diseases (Basel, Switzerland)|June 24, 2009
Systemic therapies in hepatocellular carcinomaMarcus Alexander Wörns, Arndt Weinmann, Marcus Schuchmann, et al.
Zeitschrift Fur Gastroenterologie|November 25, 2021
Prescription rates of common medications in patients with decompensated cirrhosis in GermanyChristian Labenz, Karel Kostev, Peter Robert Galle, et al.
Oncology|November 13, 2010
Sunitinib in patients with advanced hepatocellular carcinoma after progression under sorafenib treatmentMarcus Alexander Wörns, Marcus Schuchmann, Christoph Düber, et al.
Deutsches Arzteblatt International|September 21, 2017
Drug Treatment for Chronic Hepatitis C Infection and Cancer RiskMarcus-Alexander Wörns, Peter Robert Galle, Stefan Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
Pageof 9